Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study

Table 1 Survey-weighted distributions of hs-cTn in the population with full availability of four hs-cTn assays

	Normoglycemia	Prediabetes	Diabetes
No. of pts before weighting	5946	2172	1596
Concentrations of hs-cTn, ng/L^a
hs-cTnT	4.4 (3.3–6.3)	6.1 (4.5–9.1)	8.8 (5.4–14.5)
hs-cTnI (Abbott)	1.4 (0.9–2.3)	2.1 (1.4–3.2)	2.7 (1.6–5.0)
hs-cTnI (Siemens)	2.1 (1.0–4.0)	3.1 (1.7–5.5)	4.0 (2.1–7.9)
hs-cTnI (Ortho)	0.3 (0.0–0.7)	0.6 (0.2–1.2)	0.9 (0.3–2.1)
Hs-cTn concentration > 99th URL (%)^a
hs-cTnT	2.4 (0.00)	5.8 (0.00)	15.6 (0.01)
hs-cTnI (Abbott)	0.5 (0.00)	1.0 (0.00)	2.4 (0.00)
hs-cTnI (Siemens)	0.8 (0.00)	1.9 (0.00)	3.4 (0.00)
hs-cTnI (Ortho)	0.8 (0.00)	1.5 (0.00)	3.7 (0.00)
Hs-cTn concentration > LoD (%)^a
hs-cTnT	81.3 (0.01)	93.9 (0.01)	97.0 (0.01)
hs-cTnI (Abbott)	41.3 (0.01)	65.5 (0.02)	74.4 (0.02)
hs-cTnI (Siemens)	60.0 (0.02)	76.9 (0.02)	81.8 (0.02)
hs-cTnI (Ortho)	39.9 (0.01)	59.3 (0.02)	70.3 (0.02)

^aConcentrations of cardiac troponin were expressed as weighted median (interquartile range), and categorized variables were expressed as weighted proportions (standard error)
pts participants, hs-cTn high-sensitivity cardiac troponin, URL upper reference limit, LoD lower limit of detection

ISSN: 1475-2840